Doshi, P., Spence, O., Kuzucan, A., & Powers, J. H. (2019). Communication of Nonefficacy Benefits of New Drugs Approved on the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017. JAMA Intern Med.
Citação norma ChicagoDoshi, Peter, O’Mareen Spence, Aida Kuzucan, and John H. Powers. "Communication of Nonefficacy Benefits of New Drugs Approved On the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017." JAMA Intern Med 2019.
Citação norma MLADoshi, Peter, O’Mareen Spence, Aida Kuzucan, and John H. Powers. "Communication of Nonefficacy Benefits of New Drugs Approved On the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017." JAMA Intern Med 2019.